Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling protein-ligand complexes

P Bamborough1, F E Cohen

  • 1Department of Cellular and Molecular Pharmacology, University of California, San Francisco 94143-0450, USA.

Current Opinion in Structural Biology
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Viral chemokine receptors and chemokines in human cytomegalovirus trafficking and interaction with the immune system. CMV chemokine receptors.

Current topics in microbiology and immunology·2002
Same author

Engineering the prion protein using chemical synthesis.

The journal of peptide research : official journal of the American Peptide Society·2002
Same author

Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.

Journal of molecular biology·2001
Same author

The impact of whole genome sequence data on drug discovery--a malaria case study.

Molecular medicine (Cambridge, Mass.)·2001
Same author

Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same journal

Metabolic disruptions through a three-dimensional genomic lens.

Current opinion in structural biology·2026
Same journal

Collective variable design for biomolecular conformational dynamics.

Current opinion in structural biology·2026
Same journal

Polymer scaling in protein crowding: From dilute coils to semidilute meshes.

Current opinion in structural biology·2026
Same journal

Tuning the physicochemical properties of rationally designed protein-based biomolecular condensates.

Current opinion in structural biology·2026
Same journal

Editorial overview: Folding, binding and protein design.

Current opinion in structural biology·2026
Same journal

Macromolecular crowding reshapes the conformational landscapes of intrinsically disordered proteins: mechanisms, cellular contexts, and functional consequences.

Current opinion in structural biology·2026
See all related articles

Accelerating the discovery of novel biologically active compounds is crucial in pharmaceutical chemistry. Computational methods, including database searching and ligand modification, are enhancing drug discovery efficiency.

Area of Science:

  • Pharmaceutical Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • A primary objective in pharmaceutical chemistry is to increase the discovery rate of new biologically active compounds.
  • Computational methods have been developed to aid this process.
  • Algorithms have historically guided ligand evolution based on protein structure complementarity.

Purpose of the Study:

  • To explore and enhance computational methods for accelerating the identification of novel biologically active compounds.
  • To improve the efficiency of searching chemical databases for potential drug candidates.
  • To refine techniques for modifying existing active compounds and constructing new ligands based on theoretical principles.

Main Methods:

  • Utilizing algorithms for ligand evolution guided by protein structural complementarity.

Related Experiment Videos

  • Developing enhanced methods for searching large chemical databases.
  • Implementing strategies for proposing modifications to known active compounds.
  • Employing theoretical principles for the de novo construction of novel ligands.

    • Main Results:

    • Advancements in computational approaches for drug discovery.
    • Improved efficiency in identifying potential drug candidates through database searching.
    • Successful modification of known active compounds and creation of novel ligands.
    • Demonstrated potential for accelerating the identification of new biologically active molecules.

    Conclusions:

    • Computational methods offer significant potential to increase the rate of discovering new biologically active compounds.
    • Enhancements in database searching, ligand modification, and de novo design are key to advancing pharmaceutical chemistry.
    • These computational strategies are vital for the future of efficient drug discovery and development.